No reason for complacency

Patient-Centric LTOT: No Room for Complacency.

The benefits of the continuous administration of supplemental long-term oxygen therapy (LTOT) for the amelioration of the sequelae of severe chronic hypoxemia (baseline PaO2 55 mg Hg or SpO2 88%) secondary to COPD, are well established. When properly prescribed and delivered, LTOT improves survival, increases exercise tolerance, reduces dyspnea, and improves the overall quality of life in this ...

When No Reason For Is A Reason Against

We provide a Bayesian justification of the idea that, under certain conditions, the absence of an argument in favour of the truth of a hypothesis H constitutes a good argument against the truth of H.

No Room for Complacency: The Fight Against Antimicrobial Resistance

NSW immunisation performance: continuing progress but no room for complacency.

Complacency is the greatest threat to successful immunisation programs. This has recently been demonstrated in many countries in Europe with resurgence of vaccine preventable diseases that were previously well controlled, particularly measles. Thus in New South Wales (NSW), despite having a successful immunisation program, we must continue to review performance carefully, identify signals of co...

Health and economic burden of preeclampsia: no time for complacency.

reeclampsia is a common and severe pregnancy P complication and a leading cause of maternal and infant illness and death. The incidence of preeclampsia increased in the United States during the past 3 decades, and substantial evidence suggests that a history of preeclampsia is a significant risk factor for heart disease in the future years following pregnancy. In addition to adverse health cons...